Long-term treatment with sulindac in familial adenomatous polyposis: A prospective cohort study

Gastroenterology

Volumn 122, Issue 3, 2002, Pages 641-645

  CruzCorrea, Marcia ^a   Hylind, Linda M ^a   Romans, Katharine E ^a   Booker, Susan V ^a   Giardiello, Francis M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SULINDAC;

ADENOMA; ADENOMATOUS POLYP; ADULT; ARTICLE; BRONCHITIS; CLINICAL ARTICLE; COLON MUCOSA; EROSION; FAMILIAL POLYPOSIS; FEMALE; FLU LIKE SYNDROME; HUMAN; HYPERBILIRUBINEMIA; HYPOKALEMIA; LONG TERM CARE; MALE; PRIORITY JOURNAL; RECTUM CANCER; TINNITUS; VERTIGO; VILLOUS ADENOMA;

EID: 0036177847     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.31890     Document Type: Article

References (27)

1. Identification of FAP locus genes from chromosome 5q21
2. Report form the 4th biennial meeting of the leeds castle polyposis group
3. Restorative proctocolectomy and ileal reservoir
4. Rectal cancer following colectomy for polyposis
5. Rectal cancer risk in patients treated for familial adenomatous polyposis
6. The impact of familial ad]enomatous polyposis on tumorigenesis and mortality at the several organs
7. Fate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis
8. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis
9. Long-term treatment with sulindac in familial adenomatous polyposis: Is there an actual efficacy in prevention of rectal cancer?
10. Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Experience from 680 FAP families
11. Sulindac for polyposis of the colon
12. Nonsteroidal anti-inflammatory agents
13. Treatment of colonic and rectal adenomas with Sulindac in familial adenomatous polyposis
14. Sulindac causes regression of rectal polyps in familial adenomatous polyposis
15. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis
16. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment
17. Cyclooxygenase-2 expression is related to prostaglandin biosynthesis and angiogenesis in human gastric cancer
18. Prostaglandin levels in human colorectal mucosa: Effects of sulindac in patients with familial adenomatous polyposis
19. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy
20. Rectal cancer after prolonged sulindac chemoprevention
21. Ileorectal anastomosis is appropriate for a subset of patients with familial adenomatous polyposis
22. The rectum in adenomatous polyposis: The St Mark's policy
23. Rectal cancer following colectomy for polyposis
24. Colectomy with ileorectal anastomosis for familial adenomatous polyposis: The risk of rectal cancer